Efficacy and Safety of a 3-antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation
Clinical Infectious Diseases
October 2020
Efficacy and Safety of a 3-antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation
October 1, 2020 |
